TNGX14 quarters
Position history for
FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in TANGO THERAPEUTICS INC
Yes. Farallon Capital Management holds 12,277,000 shares of TNGX (Tango Therapeutics), worth $383.8M, as of its Q2 2026 13F filing. It increased the position by 3,179,589 shares (+35.0%) from Q1 2026. Farallon Capital Management has held TNGX since Q4 2024, across 7 quarterly 13F filings. TNGX is 1.8% of Farallon Capital Management's reported 13F portfolio.
Current Value
$383.8M
Current Shares
12.3M
Total Value Change
+$379.9M
Total Shares Change
+12M
Other major holders of TNGX: RTW INVESTMENTS, LP, BlackRock, Inc., FMR LLC, GOLDMAN SACHS GROUP INC